3496 related articles for article (PubMed ID: 11588941)
1. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
4. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
7. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
8. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
9. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
Ayres de Campos D; Barros H; Martinez de Oliveira J
Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
[TBL] [Abstract][Full Text] [Related]
11. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
12. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
14. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
Zárate A
Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement therapy and cancer].
Bjørge T; Tropé C
Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
[TBL] [Abstract][Full Text] [Related]
17. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
19. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in breast cancer survivors.
Xydakis AM; Sakkas EG; Mastorakos G
Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
